• Transcript of Dr. Kory's video message on the U.S. Deal to Give $1.2 Billion Taxpayer Dollars to Merck Instead of distributing safe, effective, inexpensive ivermectin

    Read More
  • Merck’s assessments of ivermectin’s efficacy in COVID-19 are in striking contrast with the findings reported by multiple expert group’s systematic reviews from across the globe.

    Read More